Financhill
Buy
60

PHG Quote, Financials, Valuation and Earnings

Last price:
$24.60
Seasonality move :
-1.17%
Day range:
$24.51 - $24.79
52-week range:
$21.48 - $32.91
Dividend yield:
3.93%
P/E ratio:
54.54x
P/S ratio:
1.21x
P/B ratio:
1.80x
Volume:
813.2K
Avg. volume:
999K
1-year change:
-5.28%
Market cap:
$22.8B
Revenue:
$19.5B
EPS (TTM):
$0.45

Analysts' Opinion

  • Consensus Rating
    Koninklijke Philips NV has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $32.43, Koninklijke Philips NV has an estimated upside of 31.84% from its current price of $24.60.
  • Price Target Downside
    According to analysts, the lowest downside price target is $26.00 representing 100% downside risk from its current price of $24.60.

Fair Value

  • According to the consensus of 3 analysts, Koninklijke Philips NV has 31.84% upside to fair value with a price target of $32.43 per share.

PHG vs. S&P 500

  • Over the past 5 trading days, Koninklijke Philips NV has overperformed the S&P 500 by 1.77% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Koninklijke Philips NV does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Koninklijke Philips NV revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Koninklijke Philips NV reported revenues of $4.3B.

Earnings Growth

  • Koninklijke Philips NV has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Koninklijke Philips NV reported earnings per share of $0.08.
Enterprise value:
29.7B
EV / Invested capital:
--
Price / LTM sales:
1.21x
EV / EBIT:
18.96x
EV / Revenue:
1.54x
PEG ratio (5yr expected):
-0.61x
EV / Free cash flow:
159.80x
Price / Operating cash flow:
125.25x
Enterprise value / EBITDA:
13.34x
Gross Profit (TTM):
$8.4B
Return On Assets:
1.34%
Net Income Margin (TTM):
2.11%
Return On Equity:
3.18%
Return On Invested Capital:
2.17%
Operating Margin:
3.78%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $18.8B $19.7B $19.3B $4.5B $4.3B
Gross Profit $7.7B $8.2B $8.4B $2B $1.9B
Operating Income -$620.7M -$442.5M $1.6B -$893.9M $163.1M
EBITDA -$1.9B -$150.1M $2.2B -$548.5M $486.1M
Diluted EPS -$2.33 -$0.94 $0.45 -$1.16 $0.08
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets -- -- -- -- $9.4B
Total Assets -- -- -- -- $29.4B
Current Liabilities -- -- -- -- $7.3B
Total Liabilities -- -- -- -- $16.7B
Total Equity -- -- -- -- $12.7B
Total Debt -- -- -- -- $8.2B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations -- -- $902.2M -$185.7M -$981.7M
Cash From Investing -- -- -$595.3M -$190.1M -$165.2M
Cash From Financing -- -- -$453.8M -$133.6M -$50.5M
Free Cash Flow -- $289.7M $185.8M -$370.4M -$1.2B
PHG
Sector
Market Cap
$22.8B
$34.9M
Price % of 52-Week High
74.75%
48.57%
Dividend Yield
3.93%
0%
Shareholder Yield
0.77%
-1.01%
1-Year Price Total Return
-5.28%
-35.06%
Beta (5-Year)
0.765
0.615
Dividend yield:
3.93%
Annualized payout:
$0.00
Payout ratio:
0.27%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $24.32
200-day SMA
Sell
Level $25.96
Bollinger Bands (100)
Buy
Level 23.05 - 25.79
Chaikin Money Flow
Buy
Level 189.4M
20-day SMA
Buy
Level $24.02
Relative Strength Index (RSI14)
Buy
Level 59.37
ADX Line
Buy
Level 15.82
Williams %R
Sell
Level -17.8744
50-day SMA
Buy
Level $23.66
MACD (12, 26)
Buy
Level 0.26
25-day Aroon Oscillator
Buy
Level 80
On Balance Volume
Neutral
Level 305M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.7531)
Sell
CA Score (Annual)
Level (-0.5552)
Buy
Beneish M-Score (Annual)
Level (-2.9916)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.533)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

Stock Forecast FAQ

In the current month, PHG has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The PHG average analyst price target in the past 3 months is $32.43.

  • Where Will Koninklijke Philips NV Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Koninklijke Philips NV share price will rise to $32.43 per share over the next 12 months.

  • What Do Analysts Say About Koninklijke Philips NV?

    Analysts are divided on their view about Koninklijke Philips NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Koninklijke Philips NV is a Sell and believe this share price will drop from its current level to $26.00.

  • What Is Koninklijke Philips NV's Price Target?

    The price target for Koninklijke Philips NV over the next 1-year time period is forecast to be $32.43 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is PHG A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Koninklijke Philips NV is a Buy. 2 of 3 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of PHG?

    You can purchase shares of Koninklijke Philips NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Koninklijke Philips NV shares.

  • What Is The Koninklijke Philips NV Share Price Today?

    Koninklijke Philips NV was last trading at $24.60 per share. This represents the most recent stock quote for Koninklijke Philips NV. Yesterday, Koninklijke Philips NV closed at $24.60 per share.

  • How To Buy Koninklijke Philips NV Stock Online?

    In order to purchase Koninklijke Philips NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Brown Forman Stock Go?
How High Will Brown Forman Stock Go?

On the surface, Brown‑Forman (NYSE: BF.B) is having an unremarkable year.…

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock